Fund HoldingsCheckpoint Capital L.P.

Total Portfolio Value
$214.59M
Total Bought
$60.16M
Total Sold
$32.54M
Net Transaction
+$27.62M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
CORCEPT THERAPEUTICS INC(CORT)5,000343,917+338,91757125,24411.76%+24,672
RHYTHM PHARMACEUTICALS INC(RYTM)907,2401,060,000+152,76048,05766,98131.21%+18,925
ARGENX SE(ARGX)115,000149,977+34,97768,06482,67038.52%+14,606
DISC MEDICINE INC(IRON)243,311265,000+21,68912,07814,0346.54%+1,956
SEPTERNA INC(SEPN)824,878586,473-238,4054,7766,1992.89%+1,423
KYMERA THERAPEUTICS INC(KYMR)136,605106,991-29,6143,7394,6692.18%+930
RAPT THERAPEUTICS INC109,8300-109,8301340-134
IMMUNOCORE HLDGS PLC(IMCR)9,0110-9,0112670-267
CIDARA THERAPEUTICS INC104,3800-104,3802,2480-2,248
TSCAN THERAPEUTICS INC2,017,6500-2,017,6502,7840-2,784
REVOLUTION MEDICINES INC(RVMD)392,011280,000-112,01113,86210,3014.80%-3,560
PROTAGONIST THERAPEUTICS INC175,18481,311-93,8738,4724,4942.09%-3,978
STOKE THERAPEUTICS INC(STOK)730,7170-730,7174,8590-4,859
SOLENO THERAPEUTICS INC172,9020-172,90212,3540-12,354
Page 1 of 1